On Tuesday, Inovio Pharmaceuticals Inc (NASDAQ: INO) was -4.55% drop from the session before settling in for the closing price of $1.98. A 52-week range for INO has been $1.30 – $4.61.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 22.92%. When this article was written, the company’s average yearly earnings per share was at 43.46%.
Inovio Pharmaceuticals Inc (INO) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Inovio Pharmaceuticals Inc stocks. The insider ownership of Inovio Pharmaceuticals Inc is 0.54%, while institutional ownership is 39.01%.
Inovio Pharmaceuticals Inc (INO) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.6 earnings per share (EPS) during the time that was better than consensus figure (set at -0.83) by 0.23. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 44.55% during the next five years compared to 22.92% growth over the previous five years of trading.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Trading Performance Indicators
You can see what Inovio Pharmaceuticals Inc (INO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.79. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 721.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.58, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -1.52 in one year’s time.
Technical Analysis of Inovio Pharmaceuticals Inc (INO)
Compared to the last year’s volume of 1.29 million, its volume of 1.17 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 14.81%.
During the past 100 days, Inovio Pharmaceuticals Inc’s (INO) raw stochastic average was set at 35.14%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1382 in the past 14 days, which was lower than the 0.1424 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.3522, while its 200-day Moving Average is $1.9999. Nevertheless, the first resistance level for the watch stands at $1.9567 in the near term. At $2.0233, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.0567. If the price goes on to break the first support level at $1.8567, it is likely to go to the next support level at $1.8233. Now, if the price goes above the second support level, the third support stands at $1.7567.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Key Stats
There are 66,730K outstanding shares of the company, which has a market capitalization of 129.85 million. As of now, sales total 220 K while income totals -107,250 K. Its latest quarter income was 0 K while its last quarter net income were -23,520 K.
